#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Diffuse large B-cell lymphoma recurrent Friedreich's ataxia Gastrooesophageal cancer Neonatal alloimmune thrombocytopenia Nasopharyngeal cancer Cutaneous lupus erythematosus Chorioretinitis Encephalitis autoimmune Cutaneous T-cell lymphoma Mantle cell lymphoma recurrent Castleman's disease Piriformis syndrome Hereditary haemorrhagic telangiectasia Rhabdomyosarcoma recurrent More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Basic Information Loeys-Dietz syndrome – Treatment Haemophilia B without inhibitors – Trials in Disease Rhabdomyosarcoma – Life with Disease Soft tissue sarcoma – Trials in Disease Indolent systemic mastocytosis Congenital nephrogenic diabetes insipidus – Basic Information Uterine leiomyosarcoma – Basic Information Mucopolysaccharidosis I – Basic Information Haemophilia B with anti factor IX – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benserazide Hydrochloride R-Azasetron Besilate Diltiazem Hydrochloride Agomelatine Rtp-026 Sodium GOVORESTAT Valganciclovir Hydrochloride Tropicamide Ritonavir Leflunomide FLUCLOXACILLIN SODIUM Donepezil Hydrochloride Ammonium Chloride Forimtamig Anhydrous Glucose Bp Cusatuzumab Metamizole Terlipressin Acetate Noradrenaline Tartrate Soya-Bean Oil Refined More therapies…

    Learn about Your Condition

    Aneurysm ruptured Mastocytosis Pancoast's tumour Atrial septal defect Laryngeal cancer stage III Wolfram syndrome VEXAS syndrome Meningioma Testicular leiomyosarcoma Colorectal cancer stage III SAPHO syndrome Liver transplant rejection Ankylosing spondylitis Delayed graft function Cytokine release syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Atezolizumab After Chemo-radiotherapy for Patients with Muscle-invasive Bladder Cancer Not Eligible for Radical Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Atezolizumab
    France

  • Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Divarasib
    • Budesonide
    • Cisplatin
    Belgium Italy The Netherlands Poland Spain Sweden

  • Study on Metronomic Chemotherapy for Children and Teenagers with Relapsed or Refractory Wilms Tumor Using Vincristine, Irinotecan, Etoposide, Temozolomide, and Isotretinoin

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Isotretinoin
    • Vinblastine Sulfate
    • Etoposide
    France

  • Study on Sodium Glycocholate and Sodium Butyrate for Calcium Absorption in Women with Obesity After Gastric Bypass

    Recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Butyrate
    • Sodium Glycocholate
    Sweden

  • Study on Apomorphine and Psilocybin for Recovery in Coma Patients with Acute Brain Injury

    Recruiting

    1 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    • Sodium Chloride
    Denmark

  • Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Darolutamide
    France Spain
Previous Page
1 … 491 492 493 494 495 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!